Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Meridian Bioscience Inc (NASDAQ:VIVO)

15.45
Delayed Data
As of Jun 23
 +0.15 / +0.98%
Today’s Change
10.75
Today|||52-Week Range
20.68
-12.71%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Rolih Susan D
Buy11/11/201615,750$16.55$260.7K-11.21%
Elagin Vecheslav A
EVP-Research & Development
Sale12/02/20167,883$17.30$136.4K-11.46%
Phillips David C
Director
Buy7/22/20167,500$18.07$135.5K-23.70%
Eberly Richard L
Sale11/16/20164,926$17.00$83.7K-8.31%
Kraeutler John A
Chairman & Chief Executive Officer
Buy11/04/20165,000$16.13$80.7K-4.33%
Baldini Lawrence J
Buy11/03/20164,900$16.00$78.4K-2.83%
Elagin Vecheslav A
EVP-Research & Development
Sale11/08/20163,650$16.27$59.4K-5.21%
Calzavara Marco
President & Managing Director
Sale11/08/20163,639$16.27$59.2K-5.21%
Kraeutler John A
Chairman & Chief Executive Officer
Sale11/08/20163,453$16.27$56.2K-5.21%
Lueke Melissa A
Chief Financial Officer & Executive Vice President
Sale11/08/20163,418$16.27$55.6K-5.21%
Page of 5